|
Optic Never: The Glaucomatous Optic Never |
|
|
1 | (14) |
|
Why is the Optic Nerve Important in the Diagnosis and management of Glaucoma? |
|
|
1 | (9) |
|
|
|
10 | (5) |
|
Optic Nerve: Clinical Examination |
|
|
15 | (8) |
|
How Should I Examine the Optic Nerve? |
|
|
15 | (2) |
|
How Does One Establish the Borders of the Nerve and Follow the Neuroretinal Rim Contour? |
|
|
17 | (1) |
|
How Does One Avoid Misinterpreting Rim Contour? |
|
|
17 | (1) |
|
How Much Asymmetry Between Neurovretinal Rims and Nerves Is Improtant? |
|
|
18 | (1) |
|
How Can I Estimate Disc Size and Compare Disc Size Between the Two Eyes? |
|
|
18 | (1) |
|
How Quickly Can I Expect Optic Never Change to Occur? |
|
|
19 | (1) |
|
If I See a Disc Hemorrhage on Healthy Appering Neuretinal Rim, How Soon Can I Expect to See a Change in the Rim? |
|
|
19 | (1) |
|
|
|
20 | (3) |
|
Optic Nerve: Heidelberg Retinal Tomography |
|
|
23 | (12) |
|
What Indices Should I Use to Help Me Interpret the Heidelberg Retinal Tomograph (HRT) Printout? |
|
|
23 | (6) |
|
How Big a Change Is Meaningful in the Numbers on an HRT Printout? |
|
|
29 | (1) |
|
How Does the HRT Detect Progression? |
|
|
29 | (4) |
|
Can I Use the HRT Clinically to Diagnose Glaucoma and Glaucomatous Progression? How Certain Can I Be that the Progression Is Real? |
|
|
33 | (1) |
|
|
|
34 | (1) |
|
Optic Nerve: Scanning Laser Polarimetry |
|
|
35 | (10) |
|
What Is the Physical Priniple Behind Scanning Laser Polarimetry (SLP)? |
|
|
35 | (2) |
|
How Is Image Quality and Artifact Assessed on the GDxVCC Printout? |
|
|
37 | (1) |
|
Can I Use the Scanning Laser Polarimetry Report to Diagnose Glauscoma? |
|
|
38 | (2) |
|
Can I Use Scanning Laser Polarimetry to Assess Progression of Optic Never Damage? |
|
|
40 | (2) |
|
|
|
42 | (3) |
|
Optic Nerve: Optical Coherence Tomography |
|
|
45 | (10) |
|
What Indices Should I Use to Help Me Interpret the OCT Optic Nerve Head Analysis Report? |
|
|
45 | (3) |
|
What Indices Should I Use to help Me Interpret the ``RNFL Thikckness Average Analysis Report'' Printout? |
|
|
48 | (1) |
|
Can OCT Detect Progression? How Big a Change Is Meaningful in the Numbers on an OCT Printout? |
|
|
49 | (2) |
|
Can Use OCT Clinically to Diagnose Glaucoma? |
|
|
51 | (1) |
|
Should I Incorporate Spectral Domain-OCT into My Practice? |
|
|
52 | (1) |
|
|
|
53 | (2) |
|
Optic Nerve: comparison of Technologies |
|
|
55 | (8) |
|
Why Image the Optic Nerve? |
|
|
55 | (5) |
|
Is One Optic Nerve Imaging Techique Better or More Promising than the Others for Helping to Dectect Glaucoma and Its Progression? |
|
|
60 | (1) |
|
Is One Imaging Technique Easier to Use and Interpret than Another? |
|
|
61 | (1) |
|
How Often Should I Image the Nerve? |
|
|
61 | (1) |
|
|
|
61 | (2) |
|
Optic Nerve: Atypical Nerves and Nerve Findings |
|
|
63 | (12) |
|
Should Peripapillary Atrophy (PPA) Concern Me? Should it Be Followed for Enlargement? |
|
|
63 | (1) |
|
In Examining Tilted Optic Discs, How Do I Distinguish Tilt vs. Glaucoma? |
|
|
64 | (3) |
|
With Optic Nerve Head Drusen (OND), How Do I Tell If Visual Field Changes Are due to Drrusen vs. Glaucoma? |
|
|
67 | (2) |
|
What Differential Diagnosis Should Be Kept in Mind When Looking at a Case of Questionable Glaucoma? |
|
|
69 | (2) |
|
|
|
71 | (4) |
|
IOP: The Importance of Intraocular Pressure |
|
|
75 | (4) |
|
Why Is Intracoular Pressure Important in Diagnosing and Treating Glaucoma? |
|
|
75 | (3) |
|
|
|
78 | (1) |
|
IOP: Instruments to Measure IOP |
|
|
79 | (8) |
|
What Is the Brief History of IOP Measurement? |
|
|
79 | (1) |
|
What Instrument(s) Most Accurately Measuresa IOP? |
|
|
80 | (3) |
|
If Goldmann Applanation is not Available During an Exam Under Anesthesia, What Instrument in the Next Most Preferred for IOP Measurement? |
|
|
83 | (1) |
|
In Cases of Croneal Transplant, Corneal Edema or Scarring, Which Instrumdent Whould be Best to Use to Obtain Accurate IOP Measurements? |
|
|
84 | (1) |
|
In Cases of Prosthetic Corneas How Can I Measure the IOP? |
|
|
84 | (1) |
|
Can I Convert the Readings of One Instrument of Those of Another? |
|
|
84 | (1) |
|
|
|
84 | (3) |
|
IOP: Central Corneal Thickness |
|
|
87 | (8) |
|
Why Has Central Conreal Thickness (CCT) Become So Important? |
|
|
87 | (1) |
|
How does Central Corneal Thickness Vary? |
|
|
88 | (1) |
|
Does CCT Predict Glaucoma? |
|
|
89 | (1) |
|
How Should I Use CCT in Clinical Practices? |
|
|
90 | (2) |
|
|
|
92 | (3) |
|
|
|
95 | (4) |
|
What Is Corneal Hysteresis and How does it Influence IOP Measurement? |
|
|
95 | (1) |
|
What Are Typical Corneal Hysteresis Values? |
|
|
96 | (1) |
|
What Is the Relationship Between CCT, IOP, and Corneal Hysteresis? |
|
|
96 | (1) |
|
Should I Invest in Newer Devices to Measure IOP that Claim Less Influence of CCT? |
|
|
97 | (1) |
|
|
|
98 | (1) |
|
|
|
99 | (6) |
|
Should I Establis a Target IOP on Every Patient? |
|
|
99 | (1) |
|
If I Decide to Set a Target IOP, How Should I Set it- Do I Use a perecent Reduction or Aim Toward an Absolute Number? |
|
|
99 | (2) |
|
How Should I Use Information About Dirunal IOP, Nocturanl Peaks, and Inter-Visit Fluctauation in Establishing a Target IOP? |
|
|
101 | (1) |
|
Are Supine and Nocturnal IOPs Important to Factor into Target Pressure Estimation? |
|
|
102 | (1) |
|
|
|
103 | (2) |
|
|
|
105 | (8) |
|
Why is IOP Fluctuation a Topic of Interest? |
|
|
105 | (1) |
|
What Factors Should Be Considered When Measuring Short-Terms IOP Fluctuation? |
|
|
106 | (1) |
|
What is the Significance of Short-Term IOP Fluctuation? |
|
|
106 | (1) |
|
What Factors Should Be Considered in Measuring Long-Terms IOP Fluctuation? |
|
|
107 | (1) |
|
What is the Siginificance of Measures of Long-Terms IOP Fluctuation? |
|
|
107 | (1) |
|
What is the Imact of Medication of Long-Term IOP Fluctuation? |
|
|
107 | (2) |
|
What is the Impact of Surgery on Short-Term and Long-Term IOP Fluctuation? |
|
|
109 | (1) |
|
How Agressive Should I Be in Eliminating Long-Term IOP Fluctuation Given the Potential Complications of Medications and Surgery? |
|
|
109 | (1) |
|
|
|
110 | (3) |
|
Gonisocopy: Why do Indentation? |
|
|
113 | (10) |
|
Which Patients Should Have Gonisocopy? |
|
|
113 | (1) |
|
Of What Use Is the Van Herick Agnle Examination? |
|
|
114 | (1) |
|
What Lens Should Be Used for Goniscopy? |
|
|
114 | (1) |
|
How Do I Pefrom Indentation Gonioscopy? |
|
|
115 | (2) |
|
What Should I Look for in the Angle? |
|
|
117 | (1) |
|
How Can I Recognize Peripheral Anterior Synechiae? |
|
|
118 | (1) |
|
How Narrow Is too Narrow? What Are the Indications for Laser Iridotomy in a Pateient with No Symptoms of Angle-closure? |
|
|
118 | (2) |
|
What Should I Know About Plateau Iris? |
|
|
120 | (1) |
|
What Racial Differences Exist in Agnle Anatomy? |
|
|
121 | (1) |
|
Can Anterior Segement Imaging by Ultrasound Biomicroscopy (UBM) or Anterior Segment OCT Replace Goniscopy? |
|
|
121 | (1) |
|
|
|
122 | (1) |
|
Visual Fields: Visual Field Test Strategies |
|
|
123 | (6) |
|
What Are the Basic Differences Between Different Visual Field Machines and Tests? |
|
|
123 | (1) |
|
What Are the Theoretial Advantages of Different Test Strategies (SAP, SITA, FDT SWAP, etc)? |
|
|
123 | (2) |
|
Is There a Visual Field Program of Choice at This Point in Time? |
|
|
125 | (1) |
|
What Visual field Program Is Best for Use in a Glaucoma Subspecialty Clinic? |
|
|
125 | (1) |
|
What Program is Best for Use in a General Clinic to Screen for Glaucoma? |
|
|
126 | (1) |
|
How Can I Convert from One Visual Field Strategy to Another to Help Me Interpret and Compare Tests? |
|
|
127 | (1) |
|
What Can be Done to Obtain Visual Field Information in a Patient Who Consistently Tests Unreliably? |
|
|
127 | (1) |
|
|
|
128 | (1) |
|
Visual Fields: Fluctuation and Progression |
|
|
129 | (10) |
|
How Do I Distinguish between Fluctuation and Ture Progressive Change on Visual Field Prinouts? |
|
|
129 | (2) |
|
How Frequently Should visual Fields be tested? |
|
|
131 | (1) |
|
What are the Methods Available for Determining Visual Field Progression? |
|
|
132 | (1) |
|
What Automated Progression Analysis Software Is Available to Help with Visual Field Interpretation? |
|
|
132 | (5) |
|
|
|
137 | (2) |
|
Visual Fields: Field Interpretation |
|
|
139 | (10) |
|
How Is Information on a Single Field Printout of the Humphrey Visual Field Analyzer Interpreted? |
|
|
139 | (3) |
|
How Is the Information on the Glaucoma Progression analysis Printout Interpreted? |
|
|
142 | (4) |
|
What Are the Pitfalls to Avoid (or Commonly Made Mistakes) in the Interpretation of Visual Fields? |
|
|
146 | (1) |
|
|
|
147 | (2) |
|
Other Tests in Glaucoma: Genetic Testing |
|
|
149 | (8) |
|
What Genetic Tests Are Currently Available to Test or Screen for Glaucoma? |
|
|
149 | (2) |
|
Are Genetic Tests for Glaucoma of Practical Use in a Clinical Setting Today, or Are They More of Theoretcial Use? |
|
|
151 | (1) |
|
How Do I Collect Samples and Where do I Send Them for Analysis? |
|
|
152 | (1) |
|
How Should the Results of Genetic Testing be Interpreted for the Patient's Use? |
|
|
153 | (2) |
|
|
|
155 | (2) |
|
Other Testing in Glaucoma: Optic Nerve Blood Flow I |
|
|
157 | (8) |
|
Should Optic Nerve Blood Flow Be Measured in Glaucoma and Glaucoma suspect Patients? |
|
|
157 | (1) |
|
Is Abnormal Ocular Blood Flow Causal in Glaucoma and Glaucoma Progression, and Does It Correlate with Disease Severity? |
|
|
158 | (1) |
|
Which Glaucoma Patients May Suffer form Ocular Blood Flow Impairment? |
|
|
158 | (2) |
|
What Are the Most Common Techniques to Measure Optic Nerve Blood flow and What Are Their Limitations? |
|
|
160 | (2) |
|
|
|
162 | (3) |
|
Other Tests in Glaucoma: Optic Nerve Blood Flow II |
|
|
165 | (10) |
|
What Evidence Is There that Vascular Alterations Play a Role in Open-Angle Glaucoma (OAG)? |
|
|
165 | (1) |
|
What Are the Positive and Negatives of Measuring Optic Nerve Blood Flow? |
|
|
166 | (1) |
|
What Technolgies Are Available to Measure Blood Flow Velocities? |
|
|
166 | (1) |
|
Are There Examples of Ocular Hemodynamice Abnormalities found in OAG Patients? |
|
|
166 | (4) |
|
How are the Results of Blood Flow Measuring Devices Interpreted and Are There Limitations to These Blood Flow Imaging Techniques? |
|
|
170 | (2) |
|
How Can the Data from Ocular Hemodynamic Studies Be Used in Clinical Practice? |
|
|
172 | (1) |
|
|
|
172 | (3) |
|
Other Tests in Glucoma: Multifocal Visual Evoked Potential |
|
|
175 | (8) |
|
What Is a Multifocal Visual Evoked Potential (mfVEP)? |
|
|
175 | (2) |
|
Who do I Interpret the Results of mfVEP Tests? |
|
|
177 | (2) |
|
Is the mfVEP a Useful Test in Glaucoma? |
|
|
179 | (1) |
|
|
|
180 | (3) |
|
|
|
183 | (8) |
|
When I Diagnose a Patient with Glaucoma for the First time, What Can I Tell him/her About the Risk of Going Blind from Glaucoma? |
|
|
183 | (1) |
|
What are the Main Risk Factors for Primary Open-Angle Glaucoma? |
|
|
184 | (3) |
|
Is the Myopic Population at Higher Risk of Glaucoma? do Myopic Patients with Glaucoma Progress Differently than Other Partients? |
|
|
187 | (1) |
|
|
|
187 | (4) |
|
Risk Factors: The Risk Calculator |
|
|
191 | (4) |
|
Is a Risk Calculator Useful? |
|
|
191 | (1) |
|
How should I Use a Risk Calculator? |
|
|
192 | (1) |
|
Can I Screen for Glaucoma with a Risk Calculator? |
|
|
193 | (1) |
|
What Does it Mean to me and My Patient If the Risk Score Is High? |
|
|
193 | (1) |
|
|
|
194 | (1) |
|
Medical Treatment: First Line Agents and Monotherapy |
|
|
195 | (8) |
|
Should Beta Blockers Still Be Used as a First-Line Agent? |
|
|
195 | (3) |
|
If a Single Agent Does Not Provide Adequate IOP Lowering, Is It Better to Switch to Another Medication in the Same Class or to Another Class, or Is It Better to Add a Second Medication? |
|
|
198 | (1) |
|
When Combing Topical Medications, do Certain Combinations Work Better Together than others, i.e., What Should I First Add to a Prostaglandia Analog or to a Beta Blocker? |
|
|
199 | (1) |
|
Should Miotics Still be used? |
|
|
200 | (1) |
|
|
|
200 | (3) |
|
Medical Treatment: The Pregnant and Nursing Woman |
|
|
203 | (4) |
|
Which Glaucoma Medications Are Safe to Use in Pregancy? |
|
|
203 | (1) |
|
What Medications Are Safe to Use in a Nursing Mother? |
|
|
204 | (1) |
|
|
|
205 | (2) |
|
Medical Treatment: Carbonic Anhydrase Inhibitors |
|
|
207 | (6) |
|
Are Oral Carbonic Anhydrase Inhibitros (CAIs) Still to Be Used Now that There Are Numerous Effective Topical Medications? |
|
|
207 | (1) |
|
How Should Oral CAIs Be Dosed? |
|
|
207 | (1) |
|
What Are the Toxic Effect of Systemic CAIs? |
|
|
208 | (1) |
|
Can CAIs Be Used in Pregnant Women or Prediatic Patients? |
|
|
209 | (1) |
|
Can CAIs Be Used in Patients with Sickle Cell Anemia? |
|
|
210 | (1) |
|
How Does Acetazolamide Differ From Methazolamdie? |
|
|
210 | (1) |
|
Are Systemic and Topical CAI Effects Additive? |
|
|
211 | (1) |
|
|
|
211 | (2) |
|
Medical Treatment: Osmotic Agents |
|
|
213 | (6) |
|
When Using Hyperosmotics Agents, What Is a Typical Dose for Acutely Elevated Intraocular Pressure (IOP)? |
|
|
213 | (3) |
|
What Systemic History Should I Gather Prior to Adminsitering Hyperosmotic Agents? |
|
|
216 | (1) |
|
Should Hyperosmotic Agents Be Used to Lower IOP Prior to Surgery? |
|
|
216 | (1) |
|
|
|
217 | (2) |
|
Medical Treatment Neuroprotection |
|
|
219 | (6) |
|
What Exactly Is Neuroprotection? |
|
|
219 | (1) |
|
What Is the Basis of Neuroprotection? |
|
|
220 | (1) |
|
What Medications Are Neuroprotective? |
|
|
221 | (2) |
|
Is There a Clinical Role for Systemic Medications in the Treatment of Glaucoma? |
|
|
223 | (1) |
|
|
|
223 | (2) |
|
Medical Treatment: Treated vs. Untreated Glaucoma and Ocular Hypertension? |
|
|
225 | (6) |
|
What Is the Natural History of Treated and Untreated Glaucoma and Ocular Hypertension? |
|
|
225 | (1) |
|
What Is the Natural History of Treated and Untreated Glaucoma? |
|
|
226 | (3) |
|
What Is the Natural History of Untreated vs. Treated Ocular Hypertension? |
|
|
229 | (1) |
|
|
|
230 | (1) |
|
Medical Treatment: Adherence and Persistence |
|
|
231 | (6) |
|
What Issues Are at Work in Patient Noncompliance? |
|
|
231 | (2) |
|
How Can One Help Patients to Be More Compliant with Treatment? |
|
|
233 | (1) |
|
How Can One Educate Patients to Realize the Long-Term Impact of Glaucoma and Encourage Adherence? |
|
|
234 | (2) |
|
|
|
236 | (1) |
|
Medical Treatment: Alternative Medicine and Glaucoma |
|
|
237 | (10) |
|
Is There Anything the Patient Can do to Improve the Outcome of their Disease Besides Using Conventional Treatments (Medications and Surgery)? |
|
|
237 | (2) |
|
When a Patient Asks about the Effect of Lifestlye on Glaucoma, How Can I Answer this with Regard to Exercise, Smoking, Alcohol, and Diet? |
|
|
239 | (2) |
|
How Should I Counsel Patients Who Inquire Regarding to Alternative and Complementary Therapy, Specifically Marijuana Use, Gingki Biloba, Bilberry, and Acupuncture? |
|
|
241 | (2) |
|
|
|
243 | (4) |
|
Procedural Treatments: Laser Trabeculoplasty |
|
|
247 | (10) |
|
Should Laser Trabeculoplasty or Medication Be Used as First-Line Treatment? How Can Trabeculoplasty be Used as Adjunctive or Replacement Treatment? |
|
|
247 | (2) |
|
Is There Still a Place for ALT Given the Availability of SLT? (In Other Words, as a Practiioner Should One Invest in Buying an SLT Laser?) |
|
|
249 | (2) |
|
When Should SLT or ALT Not Be Performed? |
|
|
251 | (1) |
|
What Are the Laser Setting and Techniques for ALT and SLT? |
|
|
251 | (1) |
|
What Pearls Are There for Performing ALT and SLT? |
|
|
252 | (1) |
|
What Complications Can I Expect and How do I Deal with Them? How Frequently Should a Patient Be Seen in follow-up After Trabeculoplasty? |
|
|
253 | (1) |
|
What Is the Mechanism of Action of ALT and SLT? |
|
|
254 | (1) |
|
What Newer Laser Trabeculoplasty Modalities Are on the Treatment Horizon? |
|
|
254 | (1) |
|
|
|
255 | (2) |
|
Procedural Treatments: Endoscopic Cyclophotocoagulation |
|
|
257 | (6) |
|
When Can or Should Endoscopic Cyclophotocoaulation (ECP) Be Used? |
|
|
257 | (1) |
|
Should ECP Be Used as a Primary Surgery for Glaucoma? |
|
|
258 | (1) |
|
Is Burning the Ciliary Processes a Safe thing to Do? |
|
|
258 | (1) |
|
Technically, How is ECP Performed? |
|
|
259 | (1) |
|
How Is the Postoperative Course of ECP Managed? |
|
|
260 | (1) |
|
What Are Complications that May Be Encountered and How Are They Specifically Managed? |
|
|
261 | (1) |
|
When Can I Expect the Pressure Drop to Occur? |
|
|
261 | (1) |
|
What Is the Long Term Safety Data on this Procedure? |
|
|
261 | (1) |
|
|
|
262 | (1) |
|
Procedural Treatments: Transcleral Cyclophotocoagulation |
|
|
263 | (8) |
|
What Is Transscleral Cyclophotocoagulation (TCP)? |
|
|
263 | (1) |
|
When should I Use TCP? Should It Be used as a Primary Surgery for Glaucoma? |
|
|
264 | (1) |
|
Technically, How Is TCP Performed? |
|
|
264 | (2) |
|
How Should One Manage the Postoperative Course? When Can One Expect the Pressure to Drop After TCP? When Can Medications Be Tapered off After TCP? |
|
|
266 | (1) |
|
What Complications May Be Encountered and How Can I Specifically Manage Each One? What is the Long-Term Efficacy and Safety Data on TCP? |
|
|
266 | (1) |
|
|
|
267 | (4) |
|
Procedural Treatments: Trabeculectomy |
|
|
271 | (8) |
|
Is a Limbus-Based Trabeculectomy Better than a Fornix-Based Trabeculectomy? |
|
|
271 | (1) |
|
Should Antimetabolites Be Used in all Cases of Trabeculectomy? |
|
|
272 | (1) |
|
Do You Adjust Antimetabolite Usage and Dose Based on Patient Age or Race? |
|
|
273 | (1) |
|
What Different Techniques Can I Utilize to Apply Mitomycin-C? |
|
|
274 | (1) |
|
Intraoperatively, What, Can I Technically do to Ensure the Best Surgical Outcome? |
|
|
275 | (1) |
|
When should I Use Adjustable Sutures? When Should I Use Laser Suture Lysis? |
|
|
276 | (1) |
|
|
|
277 | (2) |
|
Procedural Treatments: Perioperative Medication |
|
|
279 | (6) |
|
Should Topical Glaucoma Medication Be Discontinued Before Performing Trabeculectomy? |
|
|
279 | (1) |
|
What Preoperative and Postoperative Medications Are needed for Trabeculectomy? How Long Should I Continue Topical Steroid and Antibioties After Glaucoma Surgery? |
|
|
280 | (1) |
|
Which Topical Steriod Should Be Used Perioperatively? |
|
|
281 | (1) |
|
If IOP Reducation Is Needed Following Glaucoma Surgery, What Topical Medication Is Most Effective in Lowering IOP and Safest for the Trabeculectomy? Are Prostaglandins Effective in IOP Reduction After Glaucoma Surgery? |
|
|
281 | (1) |
|
How Should Anticoagulation and Antiplatelet Therapies Be Managed Perioperatively? |
|
|
282 | (1) |
|
Should Glaucoma Surgery Technique Be Modified to Reduce the Chances of Hemorrhagic Complications? |
|
|
283 | (1) |
|
|
|
284 | (1) |
|
Procedural Treatments: Bleb Needling |
|
|
285 | (8) |
|
What Are the Different Techniques to Needle a Bleb? |
|
|
285 | (4) |
|
Is It Ever Too Early or Too Late to Needle a Bleb? |
|
|
289 | (1) |
|
Are There Any Limits on How Often I Can Perform Needling and Injection of Antimetabolite? Should Antimetabolte Always Be Injected with Needling Procedures? |
|
|
290 | (1) |
|
What Complications should I Anticipate After Needling? |
|
|
290 | (1) |
|
Is It Better to Needle or Reoperate on a Failing Bleb? |
|
|
290 | (1) |
|
|
|
291 | (2) |
|
Procedural Treatments: Glaucoma Drainage Devices |
|
|
293 | (8) |
|
Is One Tube Shunt Design Better than Another at Lowering IOP? |
|
|
293 | (3) |
|
Are There Certain Cricumstances/Diagnoses Where One Type of Shunt May Be Preferred Over Another? |
|
|
296 | (1) |
|
What Kind of IOP Results Can I Expect with a tube Implant? |
|
|
297 | (1) |
|
What Are the Differences in Postoperative Course Between a Valved and Nonvalved tube Shunt? |
|
|
297 | (1) |
|
What Can I do If the Conjunctiva Will Not Close and Cover the Tube-Shunt as I am Finishing the Surgery? |
|
|
298 | (1) |
|
Should My Surgical Technique Change if the Eye Is Aphakic? |
|
|
299 | (1) |
|
Should Technique Change If the Patient Has a Great Deal of PAS? |
|
|
299 | (1) |
|
|
|
300 | (1) |
|
Procedural Treatments: New Surgical Options |
|
|
301 | (6) |
|
What New Technologies or Surgical Options Have Emerged for the Treatment of Intarocular Pressure (IOP) in Glaucoma? Is One of the New Technologies More Promising than the Others? If So, What Is the Evidence? |
|
|
301 | (5) |
|
|
|
306 | (1) |
|
Procedural Treatments: Ex-Press Mini Glaucoma Shunt |
|
|
307 | (10) |
|
How Often Is the Ex-Press Mini-Shunt Being Used In Place of More Traditional Glaucoma Surgery? Have Glaucoma Speicalists Adopted this Surgery? |
|
|
307 | (1) |
|
What Is the Ex-Press Mini-Shunt and How Does It Work? |
|
|
307 | (2) |
|
What Are the Ex-Press Mini-Shunt's Dimensions? How Is It Implanted? |
|
|
309 | (2) |
|
Should An Ex-Press Mini-Shunt's Procedure Be Performed in Place of a Trabeculectomy? |
|
|
311 | (2) |
|
How Does Surgical Technique Differe Between an Ex-Pres Shunt Porcedure and a Treabevulectomy, and What can Be Done to Obtian Better Outcome with the Procedure? |
|
|
313 | (1) |
|
What Complications Are Specific to the Ex-Press Shunt Procedure? |
|
|
314 | (1) |
|
|
|
314 | (3) |
|
Procedural Treatments: Phacotrabeculaectomy |
|
|
317 | (6) |
|
Under What Circumstances Should a Combined Phacotrabeculaectomy Be Performed? |
|
|
317 | (2) |
|
Under What Circumstances Should a Combined Phacotrabeculaectomy Not Be Performed? |
|
|
319 | (1) |
|
How Is the Postoperative Course of a Phacotrabeculectomy Different than that After the Individual Surgeries? |
|
|
319 | (1) |
|
|
|
320 | (3) |
|
Procedural Treatments: Surgery in End-Stage Glaucoma |
|
|
323 | (8) |
|
What Is End-Stage Glaucoma? |
|
|
323 | (1) |
|
Should I Operate on a Patient with End-Stage Glaucoma? |
|
|
324 | (1) |
|
What Is the Risk of Losing Remaining Vision from a Surgical Procedure in End-Stage Glaucoma Eyes? |
|
|
325 | (1) |
|
How Do Specific Complications of Surgery in End-Stage Glaucoma Lead to vision Loss? |
|
|
326 | (1) |
|
What Can Be done to Minimize Potential Vision Loss Due to Surgery in End-Stage Glaucoma? |
|
|
327 | (1) |
|
|
|
327 | (4) |
|
Glaucomas: Managing Normal-Tension Glaucoma |
|
|
331 | (6) |
|
How Low an Intraocular Pressure do I Need to Target in Normal-Tension Glaucoma? |
|
|
331 | (1) |
|
If a Patient with Normal Tension Glaucoma Is Stated on Topical Medication and the Intraocular Pressure Is Lowered 1-2mmHg, Can I Consider that to Be Adequate Treatment? |
|
|
332 | (2) |
|
What Is the Treatment of Choice in Normal-Tension Glaucoms-Medication, Laser, or Surgery? |
|
|
334 | (1) |
|
What time Course of Progression Can I Expect in Normal-Tension Glaucoma Patients and Can I Predict Who May Progress Over the Short Term? |
|
|
334 | (2) |
|
|
|
336 | (1) |
|
Glaucomas: Pseudoexfoliation Glaucoma |
|
|
337 | (8) |
|
Is There a Gene for Pseudoexfoliation Syndrome? |
|
|
337 | (1) |
|
Is Pseudoexfoliation Assoicated with Systemic Disease? |
|
|
337 | (1) |
|
What Is the Risk of Developing Glaucoma Once PXF Material Is Observed in the Eye? |
|
|
338 | (1) |
|
What Are Surgical Considerations and Management Issues in Cataract Surgery Associated with Pseudoexifoliation? |
|
|
339 | (2) |
|
|
|
341 | (4) |
|
Glaucomas: Pigment Dispersion Glaucoma and Angle Recession Glaucoma |
|
|
345 | (10) |
|
How does Glaucoma in Pigment Dispersion Syndrome Differe Clinically from Other Glaucomas? |
|
|
345 | (2) |
|
Is PDG Managed Differently than Primary Open Angle Glaucoma? |
|
|
347 | (1) |
|
Is Laser Iridotomy Recommended in PDS/PDG Patients? |
|
|
348 | (1) |
|
What Problems should Be Anticipated in PDS/PDG? What King of Outcomes can Be Expected in These Patients? |
|
|
348 | (1) |
|
How Does Glaucoma in Angle Recession Differ from Other Glaucomas? |
|
|
349 | (2) |
|
What Are the Expected Medical, Laser, and Surgical Treatment Outcomes in Angle Recession Glaucoma? |
|
|
351 | (1) |
|
What Problems should Be Anticipated in Patients with Angle Recession? |
|
|
352 | (1) |
|
|
|
352 | (3) |
|
Glaucomas: Sturge Weber Syndrome |
|
|
355 | (8) |
|
How Does Glaucoma in Struge-Weber Syndrome (SWS) Differ Clinically from Other Glaucomas? |
|
|
355 | (2) |
|
Is Management of Glaucoma in SWS Different from the Typical Management of Primary Open Angle Glaucoma (POAG)? |
|
|
357 | (2) |
|
What Problems should Be Anticipated in the Manamgment of SWS Glaucoma? |
|
|
359 | (1) |
|
What Kind of Outcomes Can Be Expected in this Type of Glaucoma? |
|
|
360 | (1) |
|
|
|
360 | (3) |
|
Glaucomas: Glaucoma and the Cornea |
|
|
363 | (8) |
|
How do Glaucoma and IOP Affect the Cornea? |
|
|
363 | (1) |
|
What Effect Does Topical Medications Have on the Corneal Endothelium and Epithelium? |
|
|
364 | (1) |
|
What Effect Does Laser Glaucoma Surgery Have on the Cornea? |
|
|
365 | (1) |
|
What Effect Does Incisional Glaucoma Surgery Have on the Cornea? |
|
|
366 | (1) |
|
How Do Corneal Diseases Affect Glaucoma? |
|
|
367 | (1) |
|
|
|
368 | (3) |
|
Glaucomas: Uveitic Glaucoma |
|
|
371 | (8) |
|
How Often Does One See Glaucoma as a Consequence of Uveitis? |
|
|
371 | (1) |
|
Is There a Way to Distinguish Between Elevated IOP Due to a Steriod Reesponse vs. Uveitic Glaucoma? |
|
|
372 | (1) |
|
How Do Inflammation Steriods Casue an Increase in IOP? |
|
|
373 | (1) |
|
When Should I Operate on Uveitic Glaucoma? |
|
|
374 | (1) |
|
Is There a Preferred Surgery for Uveitic Glaucoma (Trabeculectomy vs. Tube vs. Laser)? |
|
|
374 | (1) |
|
Is One Tube Preferred over Another in Uveitic Glaucoma? |
|
|
375 | (1) |
|
Do Prostaglandin Analogues Worsen Uveitic Inflammation? |
|
|
376 | (1) |
|
Can One Expect a Greater Inflammatory Response in Uveitics After Glaumcoma surgery? |
|
|
377 | (1) |
|
|
|
377 | (2) |
|
Glaucomas: Nevoascular Glaucoma |
|
|
379 | (10) |
|
What Medications Can Be used to Control Neovascular Glaucoma? |
|
|
379 | (2) |
|
What Is the Surgical Treatment of Choice for Neovascular Glaucoma? Should Everyone Always Get a Tube Shunt to Control IOP, i.e., Can a Trabeculectomy Be Useful? |
|
|
381 | (3) |
|
How Should PRP and Glaucoma Surgery be Timed? |
|
|
384 | (1) |
|
Is Bevacizumab Useful in Neovascular Glaumcoma? What Kind of Results and Time-course Can I Expect from Its Use? For NV of the Iris, Should It be Injected into the AnteriorChamber or Viteral Cavity? |
|
|
384 | (2) |
|
|
|
386 | (3) |
|
Pediatric Glaucoma: IOP, Axial Length, and Surgery Indications |
|
|
389 | (8) |
|
What Is the Best Way to Measure IOP in the Pediatric Patient? |
|
|
389 | (2) |
|
Is One Insturment Better than Another for Measuring IOP in the Pediatric Age Group? |
|
|
391 | (1) |
|
How Is Axial Length Measurement Used in Pediatric Glaucoma? |
|
|
391 | (1) |
|
When Should Surgery be Performed in Congenital Glaucoma, in Juvenile-Onset Glaucoma, and in Secondary Type Pediatic Glaucomas? What Factors Help Me Decide Which Procedure to Perform? |
|
|
392 | (3) |
|
|
|
395 | (2) |
|
Pediatric Glaucoma: Glaucoma Medications and Steriods |
|
|
397 | (6) |
|
Which Glaucoma medications Can Be Used Safely in Pediatic Population and How Are Medication Side Effects in the Pediatric Population Different than in Adults? |
|
|
397 | (3) |
|
Do Topical Steroids Induce a Different Steroid Response in children? |
|
|
400 | (1) |
|
|
|
401 | (2) |
|
Pediatric Glaucoma: Angle Surgery and Glaucoma Drainage Devices |
|
|
403 | (6) |
|
How Do I Perform Goniosurgery? |
|
|
403 | (3) |
|
How Do I Perform Glaucoma Drainage Devices (GDD) in Children? |
|
|
406 | (2) |
|
|
|
408 | (1) |
|
Pediatric Glaucoma: Trabeculectomy and Glaucoma Drainage Devices |
|
|
409 | (6) |
|
Is Trabeculectomy the Preferred Surgery in Children Following Angle Surgery (Goniotomy and Trabeculotomy)? |
|
|
409 | (1) |
|
Is Trabeculectomy Preferred over Tube Shunt Surgery in Children? |
|
|
410 | (1) |
|
Is There an Age Cut-Off for Performing Trabeculectomy in the Pediatric Age Group? |
|
|
410 | (1) |
|
What Factors Help-one Decide for or Against One Surgery Over the Other? |
|
|
411 | (1) |
|
What Complications and Issues Should Be Anticipated in the Intraoperative and Postoperative Periods |
|
|
411 | (1) |
|
What Can Be done Technically to Perform a Better Trabeculectomy in Kids? |
|
|
412 | (1) |
|
What Cane Be done Techinically to Perform a Better Glaucoma Drainage Device Surgery in Kids? |
|
|
413 | (1) |
|
|
|
414 | (1) |
|
Angle-Closure Glaucoma: Risk Factors |
|
|
415 | (6) |
|
Who Is at Risk for Acute Angle-Closure? |
|
|
415 | (1) |
|
Can I Predict Who Will Have an Angle-Closure Attack? |
|
|
416 | (1) |
|
What Systemic Medications Must narrow Angle Patients be Counseled Against Using? Is It Safe to Use These Medications If There Is a Patent LPI? |
|
|
417 | (1) |
|
|
|
418 | (3) |
|
Angle-Closure Glaucoma: Iridotomy |
|
|
421 | (6) |
|
What Settings Should Be Used to Perform Laser Peripheral Iridotomy (LPI)? |
|
|
421 | (1) |
|
How Does Iris Color Affect the Laser Settings? |
|
|
422 | (1) |
|
If It Is Difficult to Penetrate the Iris, What Adjustments Can Be Made to the Laser Setting |
|
|
422 | (1) |
|
What Potential Complications Should be Anticipated with Laser Peripheral Iridotomy and How Should Each One Be Managed? |
|
|
423 | (1) |
|
Under What Circumstances Is Surgical Iridectomy Indicated? How Should a Surgical Iridectomy Be Performed? |
|
|
424 | (1) |
|
|
|
425 | (2) |
|
Angle-Closure Glaucoma: Imaging |
|
|
427 | (8) |
|
Is New Imaging Technology Useful in Angle Examination? |
|
|
427 | (1) |
|
What Imaging Devices Are Currently Available to Examine the Anterior Chamber Angle? |
|
|
428 | (2) |
|
When Should UBM and AS-OCT Be Ordered: Is One Device Considered Better than the Other? |
|
|
430 | (1) |
|
How Should Test Results Be Interpreted and Used to Help Treat the Patient? |
|
|
430 | (3) |
|
|
|
433 | (2) |
|
Angle-Closure Glaucoma: Medical Therapy |
|
|
435 | (4) |
|
During and Acute Angle-Closure Attack, What Medication Are Indicated? |
|
|
435 | (1) |
|
Should Pilocarpine Be Avoided in Angle-Closure Patients? |
|
|
436 | (1) |
|
|
|
437 | (2) |
|
Angle-Closure Glaucoma: Surgical Management Of Acute Angle-Closure Glaucoma |
|
|
439 | (6) |
|
What Is the Role of Paracentesis in the Managment of Acute Angle-Closure Glaucoma? Technically, How should this Be Performed If the Anterior Chamber Is Very Shallow? |
|
|
439 | (1) |
|
Is There a Role for Cataract Extraction in Acute Angle-Closure? If Cataract Surgery Must Be Performed Under Conditions of Acute Angle-colsure, What Can Be Done to Ensure the Best Possible Outcome for the Patient? |
|
|
440 | (1) |
|
How Should Angle-Closure Due to Phacomorphic Glaucoma or Loose Zonules Be Managed? |
|
|
441 | (1) |
|
In Routine Cataract Surgery where the Patient Has an Occludable angle, should LPI Be Performed Before Cataract Extraction or Can One Proceed Directly to Cataract Surgery? |
|
|
442 | (1) |
|
|
|
443 | (2) |
|
|
|
445 | (4) |
|
What Are the Options in the Treatment of Early Postoperative Hypptony? |
|
|
445 | (2) |
|
If There Is Hypotony Maculopathy, What should Be Done to Manage It? |
|
|
447 | (1) |
|
How Can I Manage Late Hypotony due to a Scleral Melt? |
|
|
448 | (1) |
|
Which Patients Are at Risk for Hypotony? |
|
|
448 | (1) |
|
|
|
448 | (1) |
|
Complications: Bleb Leaks |
|
|
449 | (8) |
|
Does an Early Bleb Leak Need to Be Fixed? |
|
|
449 | (2) |
|
How Should I Treat a Late-Onset Bled Leak? |
|
|
451 | (3) |
|
What Can I Do to Decrease the Chances of a Future Bleb Leak? |
|
|
454 | (1) |
|
|
|
454 | (3) |
|
|
|
457 | (1) |
|
What Topical Antibiotics Should I Use in Blebitis? |
|
|
457 | (1) |
|
When should I Move on to Intravitreal Injections? |
|
|
458 | (1) |
|
How Do I Manage a Patient After the Blebitis Is Resolved? |
|
|
458 | (1) |
|
|
|
459 | |
Las personas que visitaron este libro, también visitaron los siguientes libros.
que aparece a la derecha.